Altered serotonin (5-hydroxytryptamine, 5-HT) signaling has been implicated in some developmental abnormalities of autism spectrum disorder (ASD). However, the presumed role of 5-HT in ASD raises new questions in fundamental neuroscience. Specifically, it is not clear if the current piecemeal approach to 5-HT signaling in the mammalian body is effective and whether new conceptual approaches may be required. This review briefly discusses 5-HT production and circulation in the central nervous system and outside of it, especially with regard to ASD, and proposes a more encompassing approach that questions the utility of the "neurotransmitter" concept. It then introduces the idea of a generalized 5-HT packet that may offer insights into possible links between serotonergic varicosities and blood platelets. These approaches have theoretical significance, but they are also well positioned to advance our understanding of some long-standing problems in autism research.
Introduction: Autism and fundamental neuroscience
The problem of autism is a proverbial rabbit hole that leads to problems in fundamental neuroscience. Over the past decade, autism spectrum disorder (ASD) has become an ultimate Rorschach test in neurobiology, and the pathologies that have been associated with ASD now cover a vast array of neurobiological processes and brain structures (Rodier, 2002; Courchesne et al., 2007; Amaral et al., 2008; Fatemi et al., 2012; Gadad et al., 2013; Gesundheit et al., 2013; Parellada et al., 2014; Banerjee et al., 2014) . Likewise, massive genetic studies have yielded enormous lists of potentially relevant but weakly associated genes (Anney et al., 2010; Betancur, 2011; Lee et al., 2013) , the fundamental or practical value of which has yet to be demonstrated. If ASD is defined as a specific applied problem, fundamental neurobiology thus far has contributed surprisingly little to its solution.
The current situation calls for an honest reassessment of where we truly are. A contemporary scientist is an odd cross between an objective observer unbound by the here-and-now and a merchant who needs to sell his/her goods to the public. This can and does work in many science fields, but autism research has been heavily biased toward the latter. Efforts to serve families with autistic children have a noble goal, but they are best left to applied fields seeking * Tel.: +1 805 893 6032; fax: +1 805 893 4303.
E-mail address: skirmantas.janusonis@psych.ucsb.edu to improve interventions, therapies, and treatments. Beyond that, ASD may be simply unsolvable without a much deeper understanding of the key building elements that make this condition possible. This may require major improvements in fundamental neuroscience and may contradict the public's intuition of what is important.
At present an unsettling possibility remains that ASD may be a kind of "limping syndrome" that can be easily observed and approached therapeutically, but that cannot be rigorously studied as a single neurobiological entity. A more optimistic view is that ASD is a solvable problem, but fundamental neuroscience is not ready for it (to paraphrase Paul Erdős' comments on the 3n + 1 conjecture). ASD is likely to be the tip of a large iceberg, but focusing on this visible tip may be a shortsighted approach. Instead, a few fundamental problems have to be addressed directly and immediately. The most obvious one is how normal brains align their neural activities in social interactions. Another one is the interplay between the cognitive and motor systems in the brain (which may lead to major revisions in our current understanding of the basal ganglia and the cerebellum). This brief review focuses on yet another deep problem that thus far has attracted too little attention: the integrated dynamics of serotonin (5-hydroxytryptamine, 5-HT) in the mammalian body. 
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